DE60127901D1 - TCF-1 Nukleotidsequenzvariation - Google Patents

TCF-1 Nukleotidsequenzvariation

Info

Publication number
DE60127901D1
DE60127901D1 DE60127901T DE60127901T DE60127901D1 DE 60127901 D1 DE60127901 D1 DE 60127901D1 DE 60127901 T DE60127901 T DE 60127901T DE 60127901 T DE60127901 T DE 60127901T DE 60127901 D1 DE60127901 D1 DE 60127901D1
Authority
DE
Germany
Prior art keywords
tcf
nucleotide sequence
sequence variation
diseases
atopy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60127901T
Other languages
English (en)
Other versions
DE60127901T2 (de
Inventor
Ann Bethea Begovich
Henry Anthony Erlich
Andrew Gruppe
Janelle Annette Noble
Gary Allen Peltz
Rebecca Lynne Reynolds
Karen Myra Walker
Gabriele Zangenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Publication of DE60127901D1 publication Critical patent/DE60127901D1/de
Application granted granted Critical
Publication of DE60127901T2 publication Critical patent/DE60127901T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60127901T 2000-07-21 2001-07-17 TCF-1 Nukleotidsequenzvariation Expired - Lifetime DE60127901T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21981200P 2000-07-21 2000-07-21
US219812 2000-07-21

Publications (2)

Publication Number Publication Date
DE60127901D1 true DE60127901D1 (de) 2007-05-31
DE60127901T2 DE60127901T2 (de) 2008-01-17

Family

ID=22820882

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60127901T Expired - Lifetime DE60127901T2 (de) 2000-07-21 2001-07-17 TCF-1 Nukleotidsequenzvariation

Country Status (6)

Country Link
US (2) US6656691B2 (de)
EP (1) EP1174522B1 (de)
JP (1) JP4846130B2 (de)
AT (1) ATE360094T1 (de)
DE (1) DE60127901T2 (de)
ES (1) ES2286060T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4231051B2 (ja) * 2003-08-29 2009-02-25 株式会社東芝 測定対象物質の濃度測定方法、測定対象物質の濃度測定用キット及びセンサチップ
EP1802758A4 (de) * 2004-10-01 2008-08-27 Temasek Life Sciences Lab Ltd Oslrk1 (oryza sativa lectin-like receptor kinase 1), ein an der pflanzenentwicklung beteiligtes gen
US20080268442A1 (en) * 2007-04-24 2008-10-30 Igd Intel, Llc Method and system for preparing a blood sample for a disease association gene transcript test
US20090125244A1 (en) * 2007-11-09 2009-05-14 Igd Intel Llc Broad-based neurotoxin-related gene mutation association from a gene transcript test
US8135545B2 (en) 2007-11-09 2012-03-13 Iverson Genetic Diagnostics, Inc. System and method for collecting data regarding broad-based neurotoxin-related gene mutation association

Also Published As

Publication number Publication date
EP1174522A9 (de) 2002-07-03
EP1174522A3 (de) 2004-02-18
US20030203395A1 (en) 2003-10-30
ES2286060T3 (es) 2007-12-01
US6656691B2 (en) 2003-12-02
US20030054350A1 (en) 2003-03-20
JP4846130B2 (ja) 2011-12-28
ATE360094T1 (de) 2007-05-15
EP1174522A2 (de) 2002-01-23
DE60127901T2 (de) 2008-01-17
EP1174522B1 (de) 2007-04-18
JP2002330755A (ja) 2002-11-19

Similar Documents

Publication Publication Date Title
WO2003000853A3 (en) Protein aggregation assays and uses thereof
DK1706424T3 (da) FC-region varianter
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
GB0117326D0 (en) Napthoquinone-type inhibitors of protein aggregation
HK1069767A1 (en) Methods for inhibiting ocular processes
BRPI0412184A (pt) renderização de anúncios com documentos tendo um ou mais tópicos utilizando informação de interesse de tópico do usuário
CY2008014I1 (el) Β-αμινο-τετραϋδροϊμιδαζο-(1,2-α)-πυραζινες και τετραϋδροτριαζολο-(4,3-α)-πυραζινες ως αναστολεις της διπεπτιδυλο πεπτιδασης για την αγωγη η προληψη του διαβητη
EP2236156A3 (de) Verfahren zur Behandlung und Diagnose von Psoriasis
IN2014DN05011A (de)
EP1409544A4 (de) Humane dr4-antikörper und deren anwendungen
WO2002092763A3 (en) Intron associated with myotonic dystrophy type 2 and methods of use
ATE360094T1 (de) Tcf-1 nukleotidsequenzvariation
ATE393238T1 (de) Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind
DE50204547D1 (de) Vorrichtung zur klassifizierung von personen oder objekten
WO2003063769A3 (en) Vesicle-associated proteins
EP1199372A3 (de) Polymorphismen des menschlichen P2X7 Gens
EP1234835A3 (de) Assays zum Nachweis von ABeta-Tau Aggregation
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
WO2004113566A3 (en) Disease related protein network
WO2002072883A3 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
WO2002004661A3 (en) Methods for classifying nucleic acids and polypeptides
WO2004019880A3 (en) Aw755252-interacting proteins and use thereof
ATE537257T1 (de) Mit iga-nephropathie assoziierte dns
WO2004001367A3 (de) Testsystem zum nachweis von krebserkrankungen
WO2003014391A3 (en) Method for the detection of a polymorphism in cpb2

Legal Events

Date Code Title Description
8364 No opposition during term of opposition